Search database
LIST OPTIONS
Filter
7
Filtered Results: 7
Text search: Venuti, F. et al.
Featured
Language
Document type
Studies & Reports
5
Guidelines
1
No document type
1
Countries / Regions
Italy
2
West and Central Africa
1
East and Southern Africa
1
Authors & Publishers
et al.
2
Istituto Superiore di Sanità (ISS)
2
A. Agodi
1
Comité international de la Croix-Rouge (CICR)
1
E. Beccaloni
1
F. Scaini
1
F. “P.” D’Ancona
1
L. Bertinato
1
L. Bonadonna
1
Lima, C.
1
MDPI Microorganisms
1
Tagliazucchi, L.
1
UN Convention to Combat Desertification
1
Venturelli, A.
1
Venuti, F. et al.
1
World Health Organisation (WHO)
1
World Health Organization WHO
1
Publication Years
Category
Countries
2
Clinical Guidelines
1
Toolboxes
COVID-19
3
Planetary Health
2
NTDs
1
Conflict
1
Global Health Education
1
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv... more
Rapporto ISS COVID-19, n. 3/2020 Gruppo di Lavoro ISS Ambiente e Gestione dei Rifiuti aggiornato al 14 marzo 2020
Rapporto ISS COVID-19, n. 4/2020 Gruppo di Lavoro ISS Prevenzione e Controllo delle Infezioni aggiornato al 16 marzo 2020
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th... more
27 April 2022 Chronic land degradation: UN offers stark warnings and practical remedies in Global Land Outlook 2. GLO2 offers hundreds of examples from around the world that demonstrate the potential of land restoration. The way land resources – soil, water and biodiversity – are currently mi... more
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).